About the Journal
About IJCBPI
The International Journal of Convergent Biosciences and Pharmaceutical Innovation (IJCBPI) is a peer-reviewed, open-access journal published by International Journal Press. IJCBPI publishes scholarship where biological discovery meets pharmaceutical innovation.
Scope
IJCBPI welcomes original research, reviews, and methodological contributions in translational bioscience, pharmaceutical innovation, bioinformatics and computational biology, and drug discovery and convergent methods. Submissions are judged on the soundness of their methods and the clarity of their reporting, and the journal particularly welcomes work that connects biological discovery to therapeutic and pharmaceutical advances.
Editorial standards
- Peer review: Double-blind, two-or-more reviewers, ~4-week turnaround target. See Peer Review Process.
- Ethics: COPE-aligned. See Publication Ethics.
- Originality: Similarity threshold below 15%. See Plagiarism Policy.
- Open access: CC BY 4.0; authors retain copyright. See Copyright & Licensing.
- Preservation: PKP PN, LOCKSS, DOI via Crossref. See Archiving Policy.
Audience
IJCBPI addresses researchers, scientists, and practitioners across the biosciences and pharmaceutical innovation.
Decision principle
Rigor-first editorial triage: every manuscript is assessed on methodological soundness and clarity; sound work receives constructive review and clear timelines.
Publisher
Published by International Journal Press, an open-access scholarly publisher of six independently-edited journals. Editorial enquiries: [email protected].